glp 1 tirzepatide peptide Designing a dual GLP-1R/GIPR agonist from | DDDT What Are the Pharmacodynamics of

(2021, May)

Clinical uses Type 2 Diabetes Mellitus (T2DM) : Effective in lowering blood glucose without a significant risk of hypoglycemia

The risks and side effects of the compound are not as well researched as those of the brand-name medications

Medical weight-loss therapies shift the equation for a lot of folks

Because human phenotyping studies have not demonstrated clear mechanisms as to how GLP-1 receptor agonists improve kidney outcomes, a reduction in kidney inflammation that is difficult to measure in humans remains a leading candidate mechanism

Importantly, despite their wide-spread usage, patient responses to GLP-1 M are heterogeneous